Summary

Medicinal chemistry and natural products focus on the discovery, structural characterization, synthesis, modification, and biological evaluation of bioactive molecules. This collection covers synthetic drugs, natural products, pharmacophores, structure–activity relationships, molecular interactions, drug-like properties, and the chemical and biological basis of therapeutic compound development.

Expand All
Entries
Topic Review
Terpene
Terpenes constitute a class of natural products whose carbon skeletons are assembled from repeating five-carbon isoprene (2-methyl-1,3-butadiene) units, corresponding to the general hydrocarbon formula (C₅H₈)ₙ, in which *n* denotes the number of isoprene units incorporated [1][2]. The biosynthetic precursors of all terpene skeletons are the two isomeric five-carbon building blocks isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), which are generated through two compartmentalized routes: the cytosolic mevalonate (MVA) pathway, which begins with acetyl-CoA, and the plastid-localized 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway, which derives from pyruvate and glyceraldehyde-3-phosphate [3]. Condensation of IPP with DMAPP and subsequent chain extensions by prenyltransferases yield the prenyl diphosphate intermediates of defined chain length—geranyl diphosphate (GPP, C₁₀), farnesyl diphosphate (FPP, C₁₅), and geranylgeranyl diphosphate (GGPP, C₂₀)—that serve as the immediate substrates for terpene synthases [3]. Terpene synthases (TPS) catalyze the committed, scaffold-forming step: metal-dependent ionization of the allylic diphosphate bond generates a reactive carbocation that undergoes cyclization, hydride shifts, methyl migrations, and proton transfers to produce the hydrocarbon skeleton of the terpene. The term is defined structurally by the number of C₅ units: hemiterpenes (one unit, C₅), monoterpenes (two units, C₁₀), sesquiterpenes (three units, C₁₅), diterpenes (four units, C₂₀), sesterterpenes (five units, C₂₅), triterpenes (six units, C₃₀), and tetraterpenes (eight units, C₄₀) [1]. Within the taxonomy of biosynthesis and engineering of terpenoids, the term designates this structurally defined class of isoprenoid hydrocarbons together with the enzymatic logic of TPS-mediated skeletal diversification that generates the carbon frameworks upon which downstream oxidative and functionalizing enzymes act [4].
  • 20
  • 26 Oct 2026
Topic Review
Molecular Absorption Spectroscopy
Molecular absorption spectroscopy is the spectroscopic measurement of wavelength- or frequency-dependent attenuation of electromagnetic radiation resulting from absorption by molecules undergoing transitions between quantized energy states [1]. In ultraviolet and visible molecular absorption spectroscopy, absorption occurs primarily when incident photon energies correspond to allowed transitions between molecular electronic states, particularly transitions associated with chromophoric groups [1][2]. The measured spectrum represents absorbance or a related absorption quantity as a function of wavelength, wavenumber, or frequency, thereby describing the spectral distribution and magnitude of molecular absorption [1]. Under conditions satisfying the Beer–Lambert relationship, absorbance is related to the concentration of the absorbing molecular species, optical path length, and its molar absorption coefficient [1][3]. Within biophysical and biochemical research, biomacromolecular absorption spectra arise from intrinsic or associated chromophores, including electronic structures within proteins, nucleic acids, cofactors, and other molecular constituents [2][3]. The concept therefore encompasses the physical absorption process, its spectroscopic measurement, and the molecular spectral features generated by energy-state transitions [1][2][3].
  • 23
  • 24 Oct 2026
Topic Review
Macromolecular Chemistry
Macromolecular chemistry is the branch of chemistry concerned with the molecular constitution, synthesis, stereochemistry, transformation, and structural characterization of macromolecules and polymeric substances. A macromolecule is a molecule of high relative molecular mass whose structure substantially comprises multiple repetitions of units derived, actually or conceptually, from molecules of lower relative molecular mass, while a polymer is a substance composed of macromolecules [1]. The chemical description of a macromolecular system encompasses monomer-derived constitutional units, covalent connectivity, degree of polymerization, molar-mass distribution, chain-end structure, comonomer sequence, branching, crosslinking, molecular topology, and stereochemical organization such as tacticity [1][2]. Macromolecular chemistry also encompasses the chemical reactions by which these structural features are established or transformed, including chain-growth, step-growth, ring-opening, and other polymerization processes and subsequent reactions of polymer chains [2][3]. Its defining scope therefore centers on the relationship between molecular synthesis, repeated-unit constitution, chain architecture, stereochemical arrangement, and the chemical identity of high-molar-mass molecular systems [1][2][3].
  • 15
  • 24 Oct 2026
Topic Review
Diterpenoid
A diterpenoid is a member of a structurally diverse class of C20 terpenoid natural products whose carbon frameworks are biosynthetically derived predominantly from geranylgeranyl diphosphate (GGPP) and are associated with four isoprenyl units [1]. In plants, diterpenoid formation commonly begins with enzyme-catalyzed cyclization or rearrangement of GGPP by diterpene synthases, producing characteristic hydrocarbon or oxygenated scaffolds with acyclic, bicyclic, tricyclic, tetracyclic, or macrocyclic architectures [1][2][3]. These primary scaffolds undergo subsequent enzymatic elaboration involving reactions such as hydroxylation, oxidation, reduction, glycosylation, acylation, and other modifications that generate the molecular diversity of naturally occurring plant diterpenoids [2][3]. Their defining molecular scope therefore includes the twenty-carbon terpenoid framework, its biosynthetic derivation from isoprenoid precursors, scaffold formation through diterpene-synthase chemistry, and the resulting structural elaboration produced by downstream biosynthetic enzymes [1][2][3]. Within bioactive natural diterpenoid research, the term encompasses the molecular structures, biosynthetic pathways, and enzymatically generated chemical forms constituting this class of specialized plant metabolites [2][3].
  • 13
  • 24 Oct 2026
Topic Review
Polyketide
Within the context of plant-derived bioactive compounds, a polyketide is an organic natural product whose principal carbon framework is biosynthetically assembled by polyketide synthases through successive carbon–carbon bond-forming condensations of acyl-derived building blocks [1][2]. The growing carbon chain is typically generated through decarboxylative condensation reactions involving a starter acyl unit and extender units derived from malonyl or related coenzyme A substrates, producing intermediates containing characteristic carbonyl functionality [1][3]. In plants, type III polyketide synthases constitute a major enzymatic basis for this chemistry and generally operate as homodimeric enzymes that use CoA thioesters directly during iterative chain extension [3]. The resulting polyketide framework can undergo controlled cyclization, aromatization, reduction, oxidation, and other enzymatic transformations that establish its final connectivity, oxidation state, substitution pattern, and stereochemical features. The concept therefore encompasses natural-product structures defined by polyketide-chain assembly and the chemically elaborated molecular frameworks generated from that biosynthetic carbon skeleton [1][2][3].
  • 14
  • 24 Oct 2026
Topic Review
Drug Transport Proteins
A drug binding protein is a protein that directly and reversibly associates with a therapeutic agent through a molecular binding site and thereby contributes to the agent’s cellular recognition, intracellular concentration, transmembrane movement, sequestration, metabolism, or pharmacological response. Within oncology and drug transport–resistance mechanisms, the term principally encompasses membrane proteins that bind anticancer drugs as transport substrates or inhibitors, including ATP-binding cassette (ABC) efflux transporters and solute carrier (SLC) uptake transporters [1][2][3]. Drug binding occurs through noncovalent interactions involving hydrophobic contacts, hydrogen bonds, electrostatic forces, aromatic interactions, and conformational complementarity between the drug and the protein’s binding cavity or translocation pathway. Binding affinity, substrate specificity, binding-site accessibility, transporter conformation, expression level, and coupling to ATP hydrolysis or solute gradients govern the extent of drug movement across cellular membranes [2][3][4]. In tumour cells, these protein–drug interactions regulate intracellular drug exposure and can contribute to reduced drug accumulation and multidrug-resistance phenotypes [1][3][4].
  • 14
  • 24 Oct 2026
Topic Review
Antifungal Proteins
Antifungal proteins are proteinaceous molecules that inhibit fungal growth, viability, morphogenesis, spore germination, or other cellular processes required for fungal propagation. Within fungal biology and pharmacology, the term encompasses proteins and peptides produced by fungi, plants, animals, and microorganisms that exert activity against fungal cells through defined molecular interactions [1][2]. Their structural classes include cysteine-rich disulfide-stabilized proteins, defensins, lectins, ribosome-inactivating proteins, protease inhibitors, and enzymes or protein domains with fungistatic or fungicidal activity [1][3]. Antifungal activity may involve binding to fungal cell-wall components or membrane lipids, perturbation of membrane integrity, cellular internalization, induction of reactive oxygen species, disruption of ion homeostasis, interference with cell-wall biosynthesis, or activation of regulated cell-death pathways. The defining scope of antifungal proteins comprises their molecular capacity to recognize or perturb fungal cellular structures and physiological processes, resulting in measurable suppression of fungal growth or survival [2][4].
  • 11
  • 24 Oct 2026
Topic Review
Antimicrobial Proteins
Antimicrobial proteins are proteinaceous components of innate host defense that directly impair the survival, growth, colonization, or infectivity of microorganisms. Within the taxonomy of antimicrobial peptides and activities, the term encompasses both relatively large proteins and their bioactive peptide products when these molecules possess intrinsic antimicrobial activity. Their targets include bacteria, fungi, viruses, and parasites, although the spectrum and magnitude of activity depend on the molecular structure of the protein, the target organism, and the local physicochemical environment [1][2]. Antimicrobial proteins act through diverse molecular mechanisms. These include disruption or permeabilization of microbial envelopes; enzymatic degradation of microbial structural components; sequestration of nutrients required for microbial growth, particularly metal ions; binding to microbial surface molecules; interference with intracellular microbial processes; and modulation of host immune responses that contribute to microbial control [2][3][4]. They are therefore distinguished from conventional low-molecular-weight antimicrobial drugs by their protein or peptide composition and by the frequent integration of direct microbicidal or microbiostatic effects with host-defense functions. Antimicrobial peptides constitute a structurally shorter subset of this broader proteinaceous defense system, whereas antimicrobial proteins may retain activity as intact macromolecules or release active peptide fragments after proteolytic processing [1][4].
  • 13
  • 24 Oct 2026
Topic Review
Antimicrobial Efficacy
Within microbial inactivation methods, antimicrobial efficacy is the capacity of a defined antimicrobial intervention—such as a chemical biocide, antimicrobial material, physical treatment, or biological agent—to inhibit microbial multiplication and/or to reduce the number of viable microorganisms under specified exposure conditions. It is an outcome-dependent property rather than an intrinsic synonym for the presence of antimicrobial activity: efficacy is defined only in relation to a target microorganism or microbial population, the magnitude and endpoint of the observed effect, and the controlled conditions of exposure, including agent concentration or intensity, contact time, temperature, growth state, inoculum, and test matrix [1][2]. The effect may be expressed as growth inhibition, loss of culturability, or microbial killing/inactivation, commonly quantified by minimum inhibitory or microbicidal concentrations, time–kill kinetics, or logarithmic reductions in viable counts [1][3]. Antimicrobial efficacy is therefore distinct from antimicrobial susceptibility, which characterizes the response of a microorganism to an agent under a defined test system, and from antimicrobial resistance, which denotes reduced susceptibility relative to an appropriate reference or interpretive framework. In the context of inactivation, a credible efficacy determination requires a specified microbial endpoint and standardized or otherwise explicitly described test conditions, because methodological variables directly affect the measured extent of microbial reduction [2][4].
  • 12
  • 24 Oct 2026
Topic Review
Natural Product Derivatives
Natural product derivatives are chemical compounds that retain a defined structural relationship to a naturally occurring metabolite while differing from the parent compound through chemical, enzymatic, or biosynthetically directed modification. Within natural-product bioactivity and synthesis, this category principally includes semisynthetic derivatives obtained by transformation of an isolated natural product, as well as analogues derived by modifying its biosynthetic pathway or enzymatic processing [1][2]. The parent natural product provides a recognizable molecular scaffold, whereas modifications may affect functional groups, oxidation state, stereochemical features, glycosylation pattern, substituents, or side chains [1][3]. The term is based on origin and structural lineage rather than on a specific metabolite class, biological source, or biological activity. Accordingly, derivatives can arise from alkaloid, terpenoid, polyketide, peptide, or other natural-product frameworks [2][4]. Natural product derivatives are distinguished from unmodified natural products, which are biosynthesized and isolated in their native molecular form, and from wholly synthetic compounds lacking a demonstrable scaffold-level relationship to a natural metabolite [1][3]. A derivative may preserve, remove, replace, or elaborate structural features of its parent compound, provided that its natural-product-derived core or direct biosynthetic relationship remains identifiable [2][4].
  • 16
  • 24 Oct 2026
  • Page
  • of
  • 5

Other Entry Collections

>>